A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Related Research units
Abstract
Bibliographical data
Original language | English |
---|---|
Article number | 18 |
ISSN | 1078-0432 |
Publication status | Published - 2011 |
pubmed | 21807638 |
---|